Day: July 15, 2022

UTStarcom Regains NASDAQ Listing Compliance

Written by Customer Service on July 15, 2022. Posted in Public Companies.

HANGZHOU, China, July 15, 2022 (GLOBE NEWSWIRE) — UTStarcom (“UT” or the “Company”) (NASDAQ: UTSI), a global telecommunications infrastructure provider, today announced the Company received a formal notice from NASDAQ that it has regained compliance with Listing Rule 5450(a)(1) as a result of the closing bid price of the Company’s common stock has been at $1.00 per share or greater for the last 10 consecutive business days. About UTStarcom Holdings Corp. UTStarcom is committed to helping network operators offer their customers the most innovative, reliable and cost-effective communication services. UTStarcom offers high performance advanced equipment optimized for the most rapidly growing network functions, such as mobile backhaul, metro aggregation and broadband access. UTStarcom has operations and customers around the world,...

Ascendant Amends Terms of Earn-In Agreement at Its Lagoa Salgada Project in Portugal

Written by Customer Service on July 15, 2022. Posted in Public Companies.

• Amendment Extends Deadline to Complete Feasibility Study to June 2023 • Company Targeting Completion by Q1 2023 TORONTO, July 15, 2022 (GLOBE NEWSWIRE) — Ascendant Resources Inc. (TSX: ASND, OTCQB:ASDRF) (“Ascendant” or the “Company”) is pleased to announce that it has amended the terms of the earn-in and call option agreements with Mineral & Financial Investments AG (“M&FI”) to provide the Company an extension to June 22, 2023 to complete the Feasibility Study to earn an 80% interest in the Lagoa Salgada Project (the “Project”), and will only exercise call options further diluting M&FI’s interest, and thereby maintaining the Company’s indirect 80% interest in the Project, after the sooner of 6 months post the date on which the Company increases its ownership of Redcorp to 80% or immediately post Empresa de...

Arqit and Blue Bear successfully demonstrate quantum safe military drones

Written by Customer Service on July 15, 2022. Posted in Public Companies.

Quantum encryption leader and unmanned systems supplier actively manage data security on autonomous drones in the dynamic environment of an integrated battlespace LONDON, July 15, 2022 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (“Arqit”), a leader in quantum encryption technology, and Blue Bear Systems Research Ltd. (“Blue Bear”), a pioneering supplier of unmanned and autonomous systems for defence and civil customers, today announced the successful demonstration of a quantum safe communication channel to secure data transmissions⁠—powered by Arqit’s QuantumCloud™ technology hosted on Blue Bear’s Smart Connect™ device, an ‘inter-swarm’ autonomy brain that tasks multiple uncrewed systems to deliver collaborative multi-domain missions. This is the first time C4ISR quantum safe communications with rotating symmetric keys has been enabled...

Orion Group Half-Year Financial Report 1–6/2022

Written by Customer Service on July 15, 2022. Posted in Earnings Releases And Operating Results.

ORION CORPORATION HALF-YEAR FINANCIAL REPORT 1–6/2022 15 JULY 2022 at 12:00 EEST Orion Group Half-Year Financial Report 1–6/2022 This is a summary or Orion’s Half-Year Financial Report 1–6/2022. The complete report is attached to this stock exchange release and is available at https://www.orion.fi/en/Orion-group/investors/financial-reviews-and-presentations/Net sales totalled EUR 554 million (EUR 524 million in 2021). Operating profit was EUR 153 (146) million. Profit before taxes was EUR 155 (145) million. Equity ratio was 60% (68%). Return on capital employed before taxes (ROCE) was 34% (36%). Return on equity after taxes (ROE) was 33% (32%). Basic earnings per share were EUR 0.88 (0.82). Cash flow from operating activities per share was EUR 0.59 (0.71). The outlook for 2022 was updated on 13 July 2022. Orion estimates...

HUTCHMED Initiates Phase I Trial of Anti-CD47 Monoclonal Antibody HMPL-A83 in Patients with Advanced Malignant Neoplasms in China

Written by Customer Service on July 15, 2022. Posted in Public Companies.

HMPL-A83 is the thirteenth innovative oncology drug candidate discovered in-house by HUTCHMED and its second large molecule drug candidate to enter clinical studies HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., July 15, 2022 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated a Phase I trial in China of HMPL-A83, an investigational novel IgG4-type humanized anti-CD47 monoclonal antibody. The first patient received their first dose on July 15, 2022. The Phase I trial is a multicenter, open-label study to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of HMPL-A83 in patients with advanced malignant neoplasms. The primary endpoints are dose-limiting toxicity (DLT), safety, tolerability, recommended phase II dose (RP2D) and...

Orion Corporation’s financial reporting and Annual General Meeting in 2023

Written by Customer Service on July 15, 2022. Posted in Public Companies.

ORION CORPORATION STOCK EXCHANGE RELEASE – FINANCIAL CALENDAR 15 JULY 2022 at 11.00 EEST Orion Corporation’s financial reporting and Annual General Meeting in 2023 Orion Corporation will publish its Financial Statement Release 2022 on Thursday, 9 February 2023.The publication dates of the Interim Reports and the Half-Year Financial Report in 2023 are as follows:Interim Report January-March 2023 Half-Year Financial Report January-June 2023Interim Report January-September 2023 Thursday, 27 April 2023Monday, 17 July 2023Thursday, 26 October 2023The Financial Statements and the Report of the Board of Directors for 2022 will be published on the Company’s website at the latest in week 9/2023. The Annual General Meeting is planned to be held on Wednesday, 22 March 2023. Orion’s financial reports and related...

Evli Plc’s Half Year Financial Report January-June 2022

Written by Customer Service on July 15, 2022. Posted in Earnings Releases And Operating Results.

EVLI PLC STOCK EXCHANGE RELEASE JULY 15, 2022, AT 11.00 AM (EET/EEST) OPERATING PROFIT DECREASED IN A DIFFICULT MARKET ENVIRONMENT Financial performance January-June 2022Operating income was EUR 46.2 million (1-6/2022: EUR 55.8 million) Operating profit was EUR 18.0 million (EUR 26.4 million) Operating result of the Wealth Management and Investor Clients segment decreased to EUR 15.5 million (EUR 19.1 million) Operating result of the Advisory and Corporate Clients segment decreased to EUR 2.0 million (EUR 5.7 million) At the end of June, assets under management amounted to EUR 14.5 billion (EUR 16.1 billion) on a net basis Return on equity was 28.6 percent (47.1%) The ratio of recurring revenues to operational costs was 131 percent (132%).Financial performance April-June 2022The Group’s net revenue was EUR 22.9 million (EUR...

Corbion links sustainability performance to interest rate of its new € 450 million Revolving Credit Facility

Written by Customer Service on July 15, 2022. Posted in Public Companies.

Corbion today announced that it has signed a new 5-year syndicated Revolving Credit Facility (“RCF”) with an interest rate that will, amongst others, depend on the company’s year-on-year sustainability performance improvement. The interest rate on the RCF is linked to sustainability indicators, measuring the performance of Corbion on a year-on-year basis. The indicators are linked to Corbion’s key sustainability initiatives from its Advance 2025 strategy: Preserving food and food production, health, and the planet. Based on the progress on these indicators, a discount or premium may apply to the interest rate on the RCF. “We are proud we outperformed on all the sustainability targets set out in the previous RCF which was signed in 2018. At Corbion we preserve what matters and our continued effort to align our sustainability ambitions...

Novozymes plan to further increase prices across the portfolio in response to the significant and persistent hike in incoming cost

Written by Customer Service on July 15, 2022. Posted in Public Companies.

Novozymes has experienced unprecedented cost-inflation on raw materials, energy, and logistics. To recover these headwinds, substantial price increases will be implemented. COPENHAGEN, Denmark – 15 July 2022. Novozymes has been able to partially shield its customers from a large part of the global challenges, securing business continuity and high price stability relative to other suppliers. However, Novozymes will further substantially increase prices at a level at least in line with the current and continued inflationary pressure no later than early 2023, to ensure continued innovation and supply robustness. Novozymes is committed to create a sustainable future together with our customers and partners with high performing solutions in a cost-effective manner. All customers have been or will be contacted shortly by their respective...

Nilörngruppen AB: Quarterly report update

Written by Customer Service on July 15, 2022. Posted in Earnings Releases And Operating Results.

Quarterly report updateUpdated quarterly report, where the currency effect in the text as an explanation for the quarter under other operating revenue amounts to SEK 4.6 million and not SEK 6.5 million as stated in the previous version. The currency loss under other operating expenses amounts to SEK 2.4 million. It’s just the explanatory text that’s been updated, all tables etc are unchanged. FOR FURTHER INFORMATION, CONTACT:Krister Magnusson, President & CEO Mobile: +46-704 85 21 14E-mail: krister.magnusson@nilorn.com This information is information that Nilörngruppen is under obligation to publish in accordance with the EU Market Abuse Regulation and the Securities Markets Act. The information herein was provided by the contact person named below for publication at 09:00 a.m., 15 July 2022.Attachment...

Day: July 15, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice